Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

Identification of A Novel Antibacterial Peptide from Atlantic Mackerel belonging to the GAPDH-Related Antimicrobial Family and Its In Vitro Digestibility.

Offret C, Fliss I, Bazinet L, Marette A, Beaulieu L.

Mar Drugs. 2019 Jul 12;17(7). pii: E413. doi: 10.3390/md17070413.

2.

Editorial: Application of Protective Cultures and Bacteriocins for Food Biopreservation.

Hammami R, Fliss I, Corsetti A.

Front Microbiol. 2019 Jul 4;10:1561. doi: 10.3389/fmicb.2019.01561. eCollection 2019. No abstract available.

3.

In vivo screening of multiple bacterial strains identifies Lactobacillus rhamnosus Lb102 and Bifidobacterium animalis ssp. lactis Bf141 as probiotics that improve metabolic disorders in a mouse model of obesity.

Le Barz M, Daniel N, Varin TV, Naimi S, Demers-Mathieu V, Pilon G, Audy J, Laurin É, Roy D, Urdaci MC, St-Gelais D, Fliss I, Marette A.

FASEB J. 2019 Apr;33(4):4921-4935. doi: 10.1096/fj.201801672R. Epub 2018 Dec 31.

PMID:
30596521
4.

Structure-Activity Relationships of the Bacteriocin Bactofencin A and Its Interaction with the Bacterial Membrane.

Bédard F, Fliss I, Biron E.

ACS Infect Dis. 2019 Feb 8;5(2):199-207. doi: 10.1021/acsinfecdis.8b00204. Epub 2018 Dec 24.

PMID:
30540905
5.

The Impact of Chitosan-Divergicin Film on Growth of Listeria monocytogenes in Cold-Smoked Salmon.

Benabbou R, Subirade M, Desbiens M, Fliss I.

Front Microbiol. 2018 Nov 26;9:2824. doi: 10.3389/fmicb.2018.02824. eCollection 2018.

6.

Quantitative antifungal activity of reuterin against food isolates of yeasts and moulds and its potential application in yogurt.

Vimont A, Fernandez B, Ahmed G, Fortin HP, Fliss I.

Int J Food Microbiol. 2019 Jan 16;289:182-188. doi: 10.1016/j.ijfoodmicro.2018.09.005. Epub 2018 Sep 6.

PMID:
30253311
7.

Fate and Biological Activity of the Antimicrobial Lasso Peptide Microcin J25 Under Gastrointestinal Tract Conditions.

Naimi S, Zirah S, Hammami R, Fernandez B, Rebuffat S, Fliss I.

Front Microbiol. 2018 Aug 3;9:1764. doi: 10.3389/fmicb.2018.01764. eCollection 2018.

8.

Synthesis, antimicrobial activity and conformational analysis of the class IIa bacteriocin pediocin PA-1 and analogs thereof.

Bédard F, Hammami R, Zirah S, Rebuffat S, Fliss I, Biron E.

Sci Rep. 2018 Jun 13;8(1):9029. doi: 10.1038/s41598-018-27225-3.

9.

Bacteriocinogenic properties of Escherichia coli P2C isolated from pig gastrointestinal tract: purification and characterization of microcin V.

Boubezari MT, Idoui T, Hammami R, Fernandez B, Gomaa A, Fliss I.

Arch Microbiol. 2018 Jul;200(5):771-782. doi: 10.1007/s00203-018-1482-6. Epub 2018 Feb 7.

PMID:
29417164
10.

Dual Coating of Liposomes as Encapsulating Matrix of Antimicrobial Peptides: Development and Characterization.

Gomaa AI, Martinent C, Hammami R, Fliss I, Subirade M.

Front Chem. 2017 Nov 17;5:103. doi: 10.3389/fchem.2017.00103. eCollection 2017.

11.

Study and Understanding Behavior of Alginate-Inulin Synbiotics Beads for Protection and Delivery of Antimicrobial-Producing Probiotics in Colonic Simulated Conditions.

Atia A, Gomaa A, Fernandez B, Subirade M, Fliss I.

Probiotics Antimicrob Proteins. 2018 Jun;10(2):157-167. doi: 10.1007/s12602-017-9355-x.

PMID:
29181802
12.

Isolation and Selection of Potential Probiotic Bacteria from the Pig Gastrointestinal Tract.

Lo Verso L, Lessard M, Talbot G, Fernandez B, Fliss I.

Probiotics Antimicrob Proteins. 2018 Jun;10(2):299-312. doi: 10.1007/s12602-017-9309-3.

PMID:
28744832
13.

A Syst-OMICS Approach to Ensuring Food Safety and Reducing the Economic Burden of Salmonellosis.

Emond-Rheault JG, Jeukens J, Freschi L, Kukavica-Ibrulj I, Boyle B, Dupont MJ, Colavecchio A, Barrere V, Cadieux B, Arya G, Bekal S, Berry C, Burnett E, Cavestri C, Chapin TK, Crouse A, Daigle F, Danyluk MD, Delaquis P, Dewar K, Doualla-Bell F, Fliss I, Fong K, Fournier E, Franz E, Garduno R, Gill A, Gruenheid S, Harris L, Huang CB, Huang H, Johnson R, Joly Y, Kerhoas M, Kong N, Lapointe G, Larivière L, Loignon S, Malo D, Moineau S, Mottawea W, Mukhopadhyay K, Nadon C, Nash J, Ngueng Feze I, Ogunremi D, Perets A, Pilar AV, Reimer AR, Robertson J, Rohde J, Sanderson KE, Song L, Stephan R, Tamber S, Thomassin P, Tremblay D, Usongo V, Vincent C, Wang S, Weadge JT, Wiedmann M, Wijnands L, Wilson ED, Wittum T, Yoshida C, Youfsi K, Zhu L, Weimer BC, Goodridge L, Levesque RC.

Front Microbiol. 2017 Jun 2;8:996. doi: 10.3389/fmicb.2017.00996. eCollection 2017.

14.
15.

Bacteriocin-Producing Enterococcus faecium LCW 44: A High Potential Probiotic Candidate from Raw Camel Milk.

Vimont A, Fernandez B, Hammami R, Ababsa A, Daba H, Fliss I.

Front Microbiol. 2017 May 18;8:865. doi: 10.3389/fmicb.2017.00865. eCollection 2017.

16.

Molecular and biopharmaceutical investigation of alginate-inulin synbiotic coencapsulation of probiotic to target the colon.

Atia A, Gomma AI, Fliss I, Beyssac E, Garrait G, Subirade M.

J Microencapsul. 2017 Mar;34(2):171-184. doi: 10.1080/02652048.2017.1313330. Epub 2017 Apr 19.

PMID:
28350268
17.

Lactobacillus plantarum and Its Probiotic and Food Potentialities.

Seddik HA, Bendali F, Gancel F, Fliss I, Spano G, Drider D.

Probiotics Antimicrob Proteins. 2017 Jun;9(2):111-122. doi: 10.1007/s12602-017-9264-z. Review.

PMID:
28271469
18.

Inhibition of MRSA and of Clostridium difficile by durancin 61A: synergy with bacteriocins and antibiotics.

Hanchi H, Hammami R, Gingras H, Kourda R, Bergeron MG, Ben Hamida J, Ouellette M, Fliss I.

Future Microbiol. 2017 Mar;12:205-212. doi: 10.2217/fmb-2016-0113. Epub 2017 Feb 20.

PMID:
28262046
19.

Commercial Dairy Cow Milk microRNAs Resist Digestion under Simulated Gastrointestinal Tract Conditions.

Benmoussa A, Lee CH, Laffont B, Savard P, Laugier J, Boilard E, Gilbert C, Fliss I, Provost P.

J Nutr. 2016 Nov;146(11):2206-2215. Epub 2016 Oct 5.

PMID:
27708120
21.

Study of the Ability of Bifidobacteria of Human Origin to Prevent and Treat Rotavirus Infection Using Colonic Cell and Mouse Models.

Gagnon M, Vimont A, Darveau A, Fliss I, Jean J.

PLoS One. 2016 Oct 11;11(10):e0164512. doi: 10.1371/journal.pone.0164512. eCollection 2016.

22.

ANTISTAPHYBASE: database of antimicrobial peptides (AMPs) and essential oils (EOs) against methicillin-resistant Staphylococcus aureus (MRSA) and Staphylococcus aureus.

Zouhir A, Taieb M, Lamine MA, Cherif A, Jridi T, Mahjoubi B, Mbarek S, Fliss I, Nefzi A, Sebei K, Ben Hamida J.

Arch Microbiol. 2017 Mar;199(2):215-222. doi: 10.1007/s00203-016-1293-6. Epub 2016 Sep 26.

PMID:
27671474
23.

Simultaneous Production of Formylated and Nonformylated Enterocins L50A and L50B as well as 61A, a New Glycosylated Durancin, by Enterococcus durans 61A, a Strain Isolated from Artisanal Fermented Milk in Tunisia.

Hanchi H, Hammami R, Fernandez B, Kourda R, Ben Hamida J, Fliss I.

J Agric Food Chem. 2016 May 11;64(18):3584-90. doi: 10.1021/acs.jafc.6b00700. Epub 2016 May 2.

PMID:
27111259
24.

Collagencin, an antibacterial peptide from fish collagen: Activity, structure and interaction dynamics with membrane.

Ennaas N, Hammami R, Gomaa A, Bédard F, Biron É, Subirade M, Beaulieu L, Fliss I.

Biochem Biophys Res Commun. 2016 Apr 29;473(2):642-7. doi: 10.1016/j.bbrc.2016.03.121. Epub 2016 Mar 30.

PMID:
27038545
25.

A prebiotic matrix for encapsulation of probiotics: physicochemical and microbiological study.

Atia A, Gomaa A, Fliss I, Beyssac E, Garrait G, Subirade M.

J Microencapsul. 2016 Feb;33(1):89-101. doi: 10.3109/02652048.2015.1134688. Epub 2016 Jan 25.

PMID:
26805512
26.

Efficacy of oxidizing disinfectants at inactivating murine norovirus on ready-to-eat foods.

Girard M, Mattison K, Fliss I, Jean J.

Int J Food Microbiol. 2016 Feb 16;219:7-11. doi: 10.1016/j.ijfoodmicro.2015.11.015. Epub 2015 Nov 30.

PMID:
26686597
27.

Digestibility and prebiotic properties of potato rhamnogalacturonan I polysaccharide and its galactose-rich oligosaccharides/oligomers.

Khodaei N, Fernandez B, Fliss I, Karboune S.

Carbohydr Polym. 2016 Jan 20;136:1074-84. doi: 10.1016/j.carbpol.2015.09.106. Epub 2015 Oct 23.

PMID:
26572449
28.

Nisin is an effective inhibitor of Clostridium difficile vegetative cells and spore germination.

Le Lay C, Dridi L, Bergeron MG, Ouellette M, Fliss IL.

J Med Microbiol. 2016 Feb;65(2):169-75. doi: 10.1099/jmm.0.000202. Epub 2015 Nov 9.

PMID:
26555543
29.

On Lactococcus lactis UL719 competitivity and nisin (Nisaplin(®)) capacity to inhibit Clostridium difficile in a model of human colon.

Le Lay C, Fernandez B, Hammami R, Ouellette M, Fliss I.

Front Microbiol. 2015 Sep 25;6:1020. doi: 10.3389/fmicb.2015.01020. eCollection 2015.

30.

Stability of Secondary and Tertiary Structures of Virus-Like Particles Representing Noroviruses: Effects of pH, Ionic Strength, and Temperature and Implications for Adhesion to Surfaces.

Samandoulgou I, Hammami R, Morales Rayas R, Fliss I, Jean J.

Appl Environ Microbiol. 2015 Nov;81(22):7680-6. doi: 10.1128/AEM.01278-15. Epub 2015 Aug 21.

31.

Symbiotic maple saps minimize disruption of the mice intestinal microbiota after oral antibiotic administration.

Hammami R, Ben Abdallah N, Barbeau J, Fliss I.

Int J Food Sci Nutr. 2015;66(6):665-71. doi: 10.3109/09637486.2015.1071340. Epub 2015 Jul 28.

PMID:
26218660
32.

Zeta Potential and Aggregation of Virus-Like Particle of Human Norovirus and Feline Calicivirus Under Different Physicochemical Conditions.

Samandoulgou I, Fliss I, Jean J.

Food Environ Virol. 2015 Sep;7(3):249-60. doi: 10.1007/s12560-015-9198-0. Epub 2015 May 23.

PMID:
26001534
33.

Purification and characterization of four antibacterial peptides from protamex hydrolysate of Atlantic mackerel (Scomber scombrus) by-products.

Ennaas N, Hammami R, Beaulieu L, Fliss I.

Biochem Biophys Res Commun. 2015 Jul 3;462(3):195-200. doi: 10.1016/j.bbrc.2015.04.091. Epub 2015 Apr 28.

PMID:
25934151
34.

Efficacy and mechanisms of murine norovirus inhibition by pulsed-light technology.

Vimont A, Fliss I, Jean J.

Appl Environ Microbiol. 2015 Apr;81(8):2950-7. doi: 10.1128/AEM.03840-14. Epub 2015 Feb 13.

35.

Lasso-inspired peptides with distinct antibacterial mechanisms.

Hammami R, Bédard F, Gomaa A, Subirade M, Biron E, Fliss I.

Amino Acids. 2015 Feb;47(2):417-28. doi: 10.1007/s00726-014-1877-x. Epub 2014 Dec 4.

PMID:
25466905
36.

Study of the virucidal potential of organic peroxyacids against norovirus on food-contact surfaces.

Vimont A, Fliss I, Jean J.

Food Environ Virol. 2015 Mar;7(1):49-57. doi: 10.1007/s12560-014-9174-0. Epub 2014 Nov 22.

PMID:
25416069
37.

Bacteriocinogenic properties and in vitro probiotic potential of enterococci from Tunisian dairy products.

Hanchi H, Hammami R, Kourda R, Hamida JB, Fliss I.

Arch Microbiol. 2014 May;196(5):331-44. doi: 10.1007/s00203-014-0978-y. Epub 2014 Mar 14.

PMID:
24627155
38.

Antibacterial properties and mode of action of new triaryl butene citrate compounds.

El Arbi M, Théolier J, Pigeon P, Jellali K, Trigui F, Top S, Aifa S, Fliss I, Jaouen G, Hammami R.

Eur J Med Chem. 2014 Apr 9;76:408-13. doi: 10.1016/j.ejmech.2014.02.037. Epub 2014 Feb 14.

PMID:
24602786
39.

Pediococcus acidilactici UL5 and Lactococcus lactis ATCC 11454 are able to survive and express their bacteriocin genes under simulated gastrointestinal conditions.

Fernandez B, Hammami R, Savard P, Jean J, Fliss I.

J Appl Microbiol. 2014 Mar;116(3):677-88. doi: 10.1111/jam.12391. Epub 2013 Nov 26.

40.

Identification and Partial Characterization of Antilisterial Compounds Produced by Dairy Yeasts.

Hatoum R, Labrie S, Fliss I.

Probiotics Antimicrob Proteins. 2013 Mar;5(1):8-17. doi: 10.1007/s12602-012-9109-8.

PMID:
26782600
41.

Antimicrobial and probiotic properties of yeasts: from fundamental to novel applications.

Hatoum R, Labrie S, Fliss I.

Front Microbiol. 2012 Dec 19;3:421. doi: 10.3389/fmicb.2012.00421. eCollection 2012.

42.

Stability and Inhibitory Activity of Pediocin PA-1 Against Listeria sp. in Simulated Physiological Conditions of the Human Terminal Ileum.

Le Blay G, Hammami R, Lacroix C, Fliss I.

Probiotics Antimicrob Proteins. 2012 Dec;4(4):250-8. doi: 10.1007/s12602-012-9111-1.

PMID:
26782185
43.

Growth, acid production and bacteriocin production by probiotic candidates under simulated colonic conditions.

Fernandez B, Le Lay C, Jean J, Fliss I.

J Appl Microbiol. 2013 Mar;114(3):877-85. doi: 10.1111/jam.12081. Epub 2012 Dec 27.

44.

Anti-infective properties of bacteriocins: an update.

Hammami R, Fernandez B, Lacroix C, Fliss I.

Cell Mol Life Sci. 2013 Aug;70(16):2947-67. doi: 10.1007/s00018-012-1202-3. Epub 2012 Oct 30. Review.

PMID:
23109101
45.

Colistin A and colistin B among inhibitory substances of Paenibacillus polymyxa JB05-01-1.

Naghmouchi K, Hammami R, Fliss I, Teather R, Baah J, Drider D.

Arch Microbiol. 2012 May;194(5):363-70. doi: 10.1007/s00203-011-0764-z. Epub 2011 Oct 30.

PMID:
22038095
46.

Viability of probiotic bacteria in maple sap products under storage and gastrointestinal conditions.

Khalf M, Dabour N, Kheadr E, Fliss I.

Bioresour Technol. 2010 Oct;101(20):7966-72. doi: 10.1016/j.biortech.2010.05.053. Epub 2010 Jun 8.

PMID:
20965125
47.

A new structure-based classification of gram-positive bacteriocins.

Zouhir A, Hammami R, Fliss I, Hamida JB.

Protein J. 2010 Aug;29(6):432-9. doi: 10.1007/s10930-010-9270-4.

PMID:
20676925
48.

Current trends in antimicrobial agent research: chemo- and bioinformatics approaches.

Hammami R, Fliss I.

Drug Discov Today. 2010 Jul;15(13-14):540-6. doi: 10.1016/j.drudis.2010.05.002. Epub 2010 May 26. Review.

PMID:
20546918
49.

BACTIBASE second release: a database and tool platform for bacteriocin characterization.

Hammami R, Zouhir A, Le Lay C, Ben Hamida J, Fliss I.

BMC Microbiol. 2010 Jan 27;10:22. doi: 10.1186/1471-2180-10-22.

50.

Study of the physicochemical and biological stability of pediocin PA-1 in the upper gastrointestinal tract conditions using a dynamic in vitro model.

Kheadr E, Zihler A, Dabour N, Lacroix C, Le Blay G, Fliss I.

J Appl Microbiol. 2010 Jul;109(1):54-64. doi: 10.1111/j.1365-2672.2009.04644.x. Epub 2009 Dec 4.

Supplemental Content

Support Center